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Gout has been recognized since antiquity as a clinical
disease.

It Has originally ca.lled !lodagra from the Greek pous,

foot and agra meaning attack.

The term gout is derived from

the Latin, gutta meaning drop.23

Stedman's Eedical Dictionary

defines gout as tla disease of metabolism characterized by recurrent
attacks of arthritis, particularly in the metatarsophalangeal joint
of the great toe, though any joint may be attacked, by depOSits
of sodiu..1!l biurate in and around the affected joints, and by
inflammation of fibrous structures els~ihere. 11_21 The term gout may
also be used to describe acute or chronic gouty arthritis or chronic
deforming gouty arthritis.
¥.J.storically gout has been a1luded to in many ancient "r.ritings.
For example, ,,,,e find in the Old Testament in 2 Chronicles, chapter
16, verse 12, "In the thirty-ninth year of his reign Asa was
diseased· :Lr: his feet, and his disease became severe; yet even in
his disease he did not seek the Lord, but sought
physicians. ul2
referred to in

he~p

from

It is certainly highly probable that the disease
th=~s

passage of Scripture was gout, e.nd this l"'aS

wri t ten before the founde.tion of the :a.oman empire!

Hippocrates,

460-370 B.C., knew gout as the umlalkable disease • .l l Likewise, many
famous persons in history have had or are thought to have had gout.
A,'Uong these are:

Achilles, Oedipus, Henry VII, Hartin ruther,

Henry VIII, John 'hi'esley, John Calvin, Francis Bacon, Oliver
1

Cromwell, Alexander the Great, Benjamin Fr£illklin, Louis XIV,
Goethe, New-ton and Charles Dandn.23

It has been estimated that

approximately 800, 000 persons hl the United States alone suffer
from gout so it is not a rar-e condi t-Lon. }I

HOvT many of those ,,;:ho

suffer vIi. th gouty arthritis which is undiagnosed and untreated is
anybody's guess.

Since gout is one of the only types of arthritic

condition whj_ch can be successfully treated it is indeed a pity that
anyone should suffer from this disease.
EPID111UOLOGY
As mentioned above there are approximately 800,000 gout
sufferers in the United States alone not to mention the untold
thousands throughout the rest of the world. 9

The incidence of gout

can only be estimat-ed hOvIever, so there is a large divergence of
opinion regarding the actual incidence.
prevalent disease and
severe cases.

one~lhich

At

~ny

rate it is a fairly

causes almost intolerable pp.J.n in

Sidney Smith, an eighteenth-century clergyman, wrote,

f'1men I have gout I feel

2,8

if I were walking on

ill,!

eyeballs. 11,5

Gout has by far its greatest incidence in the male.
generally agreed that the sex incidence is
females. 5.,1?.:,~;3

It is

95.5% medes 2nd j.+.5%

No good explenation ha:3 been given for this aberr;mt

sex ratio but a number of possibilities have been suggested.

It is

thought that the ratio may be attributed to the hereditary transmission of gout.

It has also been hypothesized that it may be due

to a low fertility rate among married women 1II.rith gout. 23
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It has also

been suggested tha.t 1rIOmen can tolerate a higher uric acid level ",'ithout showing the overt clinical manifestations of gout.

vmatever the

Cfmse the sex r2tio of 95.5/L5 has been well documented clinicp~ly.
The average age of onset of clinical manifestations of gout is
about

115,

but the first attack may occur as early as the first decade

of 1ife. 5,23

Other individuals may not have clinical gout until the

3th or 9th decade of life.

"mo

It is highly probable that individu.?~s

do not develop clinical gout until late ir life have haJ a high

serum uric acid for mp.ny years but for some reason have not
develoned the manifestations until late.
The race distribution of gout has not been well documented.
Gout has been described in all parts of the world.

It has been

previously assumed that Ni3groes 111ere more or less free of the
disea.se, but as better methods of diagnosis are found and more
interest is generated in gout it is being reported vuth greater
frequency in Negroes. 2J
A sea.sonal incidence of acute attacks of gout has been described.

It haB been reported that attacks occur 1l1..Qst corn:monly in

early spring and late fall. 2~9

This seems to correspond ~lith

appa.rent changes in other t;}rpefo of arthritic em.d rheum3tic condi tions which occur during changes in barometric pressure ?.nd which
allo1rl'S the rheumatism sufferer to predict changes in the l"eather.
It haC" been

f01"'t~.erly

thought that gout was due to over indul-

gence in alcohol or food '~an'd . that theref'ore ..i t:.was a dise.ase of

-3-

wealthy persons rather than the poor.

However, 1\fe nov] know that

gout is an hereditary disease and thus it attacks rich and poor
alike. 23
ETIOIDGY
Gout is one of a gro-vling number of diseases resulting from
Q

a so-called "inborn error of metabolism ll . "

That gout was associated

with uric acid has been knmm for many years.
normally

occUl~ring

product of metabolism.

Uric acid is a

Persons v.dth gout

apparently produce an excess of this substance al':: evidenced by the
fact that some gout patients have been shOlm to excrete excessive
amounts of uric 8.cid 'ltJhile on a low purine diet.

Thus the uric acid

concentration in the serum of gout natients is probably a result
of overproduction rather than inability to excrete uric acid.
Hm-leyer, a number of other nossible causes for increased uric acid
levels are believed to contribute to this condition.
decreased destruction of enzymes.

For example,

It has been thought that a

decreased destruction of the enzyme uricase was a possible factor
in the occurrence of goutJ',1t,,23

However, it is knovill that allan-

to in is the degradation product of uric c.cid in lower animals so
uricase in man should result in this same end product.

Nongouty

hump.ns, however, excrete only very small amounts of this substance
daily so it hardly seems likely that a deficiency of uricase could
result in full-blmm gout. ?3)
Another popu12T theory of the etiology of gout centers eround
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a diminished excretion of urates

b~,

the kic'Iney.

Here again is a

theorJ that does not stand UP under close scrutiny.
urate concentration in the

sel~l

If a high

is due to poor excretion by the

kidney then other substances excreted by the kidney should also
be improperly excreted.

This is not found to be the case.

patients frequently e:{hibit no other abnormal functions.

Gout
Also,

studies evaluating the renal excretion of urates reveal little or
no difference between gout patients and nongouty persons. 2J

If

renal impairment produced elevated uric acid levels and subsequent
gout then we would expect patients vlith glomerular damage to
exhibit elevated urate concentrations if not clinical gout.

This,

of course, has not been found to be the case.
The most satisfactory explanation for the metabolic deficiency
producing gout is that there is 2n increase in uric acid forma.tion
resulting in an increase in the metabolic pool.2(3 This explana.tion
would be consistent .dth the increased excretion of urates frequently noted in gout patients.
URIC ACID I'mTABOLI8M

Uric acid is the end product of purine metabolism in man,
but in the sub-primate ma1llillals the uric acid is further oxidized to
al18ntoin by the action of uricase.

Thus in such ani..rllals the

principal end product of purine metabolism is allan to in instead of
uric acid.:z.

In humans urea is the end-product of nitrogenous

substances such

8$

those of amino acid and pyrimidin origin.

-5-

In

birds and reptiles uric acid is synthesized, and thus corresponds
in its function to urea in man.

Uric acid is apparently excreted

in humans in almost constant a.'11ounts.

Dietary

intak~

except for

purine and nucleic acid substances,does not effect uric acid
excretion to any great extent.

The purine ring is made up of

8

nu,>nber of constituents including glycine, which fUrnishef' carbon
atoms

4

e~d

5,

carbon dioxide fUrnishing carbon atom

8.t0!11 7, and atoms 2 and 8 are supplied by formate.

6, nitrogen
The other

nitrogen atoms come from glutamine and aspartic acid.21
The metabolism of uric acid in man hac' been studied most
extensively by the use of isotopically labeled uric acid.
accomnlished by N15 in carbon atoms 1 and 3.

This is

Single doses of the

labeled uric acid were injected intravenously into a normal hUi'nan
'7

subject and into patients suffering from gout. L

The dilution of the

injected labeled compound was used to calculate the quantity of
uric acid 1\l'hich is present in the body water.
called the !fmiscible poolll.

This quantity is

In normal subjects the miscible pool

contains an. average of about 1130 mg. of uric acid.
gout, the miscible pool was much larger.

In subjects w-ith

In a mild case of gout

...-ith a serum uric acid of 6.9 rug./IOO ml. and no S;Yll1ptoT~lS the
miscible pool contains about

4740

mg. of uric acid and ranges up

to 31,000 mg. in patients with severe symptomsJ
It is possible to estimate the "turn-over u of uric acid from
the rate at which the N15 declines in the uric acid and this is the

-6-

rate at which uric acid is s;ynthesized and lost from the body.

It

has been found that the uric acid formed in the normal subject is
from 500-580 mg. per d2_Y.

Due to the fact that the quantities of

uric acid entering the miscible pool are

~Teater

than those lost

by the urin2ry route it was found that some of the uric acid is
not excreted but is broken dOvID chemically.
acid is excreted in the bile.

Some of this uric

Imother portion,hov.1'6ver, is degraded

to other nitrogenous products.'l
Uric acid is only slightly soluble and tends to precipitate in
acid urine upon standing.

F'ig. 1.

This factor is probably responsible for

Pathways of Purine !1etabolism in the Human Body
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CLINICAL DESCRIPTION
The first sign of gout is usually an acute attack of arthritis
in one or more of the joints of the extremities, and the diagnosis

of gout is usually not suspected until after this first attack
of arthritis.

It is generally felt that a diagnosis should not be

made until after this event.

other prodromal signs include such

things as elevated blood pressure, albuminuria, and renal stones. 2Di
These la.tter findings may also remain manifestefter the initial
episode of erticular distress.
The initial joint distress may appear at any time of the day
or night 8n:j at any tirEe of the year.

The onset is sudden and

usually involves the metatarsal-phalangeal joint of the great toe of
either or both feet.

The pain of any attack of gout including the

first enisode is often so severe as to be completely incapacitating. 5,9,23

It is generally held that the severe 9ain of gout is

due to effusion into the joint cavity and by edema of the surrounding
tissues.

Severel joints may be involved simultaneously during an

acute attack, or several joints may be involved successively as in
migratory polyarthritis of rheumatic fever.

A gout infected joint

may also be confused 1>.D-th a septic process in that the cardinal signs
of inflalmnation ere present. 23,

This inflammation often extends

beyond the affected joint to involve the lymphatics as in a
cellulitis.

It is apparent thpt one must differentiate between a

septic joint and

8.

gouty joint so that incision end drainage will

-8-

not be attempted on a gouty joint or neglected on a septic one.

In

a gouty joint the skin is tense and shiny, and the color is better
described as a cyanotic purple than a fiery red.;),23

This is not

always the case, however, and it should be pointed out that acute
gouty joint involvement may occasionally be indistinguishable
clinically from joint sepsis.

The systemic reaction to acute gout

may be even more difficult to distinguish from sepsis.

The acute

attack of gout may be accompanied by fever, chills, anorexia,
headache, and a general feeling of malaise.

other points in the

clinical picture to look for include the exquisite tenderness of
the involved joint, engorgement of the veins in the region, and
edema

~mich

may extend well beyond the limits of the involved joint.

Another characteristic sign of gouty arthritis occurs after about
a week and is found in none of the other arthritides.

This is the

desquamation of the skin over the affected joint, and may resemble
cellulitis in its appearance. 2J
The diagnosis of gout although fairly easy to make is frequently
rr.issed because the clinician fails to consider gout when a patient
has an acutely inflamed joint.

Also, many clinicians look upon

gout as primarily a European disease occurring predominantly in
persons ~mo drink excessive amomnts of beer.~ Excessive indulgence
in either food or drink as a cause of gout has not been born out
clinically although such overindulgence has been implicated in
precipitating an acute attack in persons who suffer from gout..5,19,.fQ
-9-

A number of other substances or factors are likewise suspected in
precipitating acute attacks.

These include drugs, sex, trauma,

blood loss, acute infections, prolonged bed rest, and surgical
procedures. '23
Drugs which have been implicated as inciting agents include
vitamin B12, insulin, diuretics, thiamine chloride, ergotamine
tartrate, and penicillin. 23

The fact that penicillin has been shown

to precipitate attacks of gout and to aggravate the condition when
it exists is

~;mother

good reason for making a reasonable effort

to differentiate between gout and sepsis in a case of an acutely
inflammed joint.

However, the fact that a specific drug has

been implicated as an inciting agent in gout should never prevent
a physician from using that drug when indicated by other pre-existing
or concomitant conditions.
careful consideration

Such drugs should not be used w"ithout

ho~~ver.

Direct trauma as a precipitating c>gent in gout

me~

be readily

explained by the f2ct that there is frequently urate deposition in
persons subject to gout and a blow to such an area could more
easily produce acute inflammation.
especially

ce~eful

Persons vuth gout should be

to have properly fitted shoes because ill-fitting

shoes could easily provide sufficient trauma to precipitate an
attack of gout.
The most important feature in the early diagnosis of gout and
gouty arthritis if' the history.5

First of all a family history of

gout should immediately alert the attending physician to the
-10-

possibility of gout as the diagnosis.

Like\~d.se,

the history of

the onset of the acute attack should lead to the correct diagnosis.
Chcracteristic of an acute attack of gout is the speed of onset.
A typical story

ffiRY

be that the patient goes to bed feeling

perfectly iiell and awakens a few hours later v..D. th excruciating pain
and swelling usually in the great toe of either foot.5

The severity

of the pein is another differentiating point in making the diagnosis
of gout.

The pain may be so severe that even the Yl3ight of bedding

is intolerable.

'The duration of the first attack also aids in

mru<ing the diagnosis of gout.

The usual duration of the first

attack is from five days to about ten days or two \veeks. 5

T'ne

s;;nnptoms usually disappear rather suddenly leaving the patient •.nth
no residual contplaints.

Another notable characteristic of gout

is the periodicity of the attacks which usually occur every six
months to year and

8

half.

The attacks gradually become H:ore

frequent and a more chronic phase is reached, usually after about
two decades, in which the pain and discomfort may be almost constant.

This is usually knm.'I1 as the chronic tophacious phase.

Between the acute attacks in patients without joilnt deforrr..ities
there a:e no overt signs or sympto:ns.

'1'hese periods of quiescence

in the course of gout are known as the intercritical periods. 20
The tophi, which are used by all too many clinicians as
diagnostic criteria, but which usually do not appear until well
after the diagnosis should h:?Ve been made, are the result of urate
-11-

deposition in subcutaneous tissues.
uric acid and are not

usu2~ly

These urates are the salts of

deposited as subcutaneous tophi until

the gout has been present for some tLme; however, tophi
be present by the tiIl1e of the first attack.

m~

rarely

The classical site of

tophi is on the ear, and these may be identified as white nodules
on the helix in long standing

C2~ses

of gout.

Other common si tea

for tophi include subcutaneous tissues over joints of the hands
and feet, the olecrrul0n bursa, the knees, and, less

COID~Only,

the

buttocks. 2;.3
Another

~~portant

diagnostic feature in gout is the elevation

in the serum uric acid concentration.

This elevation is invariably

found in gout patients, but an increased concentration of uric acid
does not always produce clinical gout.

Gouty p2tients have elevated

uric acid levels before and during acute attacks as well aEi during
the intercritical periods

~~ess

uricosuric agents are administered.

The normal leve1 for uric acid in the serum is 2 to

:5 mg./lOO mI.

Gouty patients usually have serum uric acid levels of 6 mg./lOO ml.
or greater.

Uric Bcid levels of 10 to 12 mg./IOO ml. are not

infrequent in gouty patients. 7,23
Other criteria ltlhich may aid in making the initial diagnosis
of gout include urate stones or calculi, albuminuria, hypertension,
and increased sedimentation rates. 2 ,3

As a matter of fact, urate

lithiasis and hypertension may precede the initial attack.
In addition to laboratory diagnostic aids we would most certainly

-12-

wi.sh to make use of radiographic evidence..

However, it must be

noted that gouty patients do not always exhibit abnormalities
detectable by X-ray so roentgenographic studies may be counted on
only for aid in the diagnosis of gout, and only in some of the patients.

In any case, hO't1fever, reQiographic studies should be employed

'n any patient suspected of having gout.
The metatarsal-phalangeal joint of the great toe is often one
of the first

~reas

to show changes on X-ray.

There is usually a

narro1rung of the joint space with bony overgrowth at the joint
margins.

'I'here

ffi2JT

also be

sorr~e

decrease in density of the head of

the first metatarsal adjacent to the joint space.

Soft tissue

swelling is also usually in evidence even =_n the absence of other
demonstrable bony changes during the acute phase of the disease.
1bphi are exhibited on X-ray as circular or ovoid areas of decreased
density with distinct and sharply defined margins. 23
One other factorvlhich may be of diagnostic value is the
response of the p2,tient to concllicine therapy..

It is generally held

that if colchicine is used for diagnosis full therapeutic amounts
should be given.
w~th

Likewise, since colchicine therapy may interfere

results of laboratory tests for gout, any patient taking

colchicine or any other uricosuric drug should have those drugs
withheld for h8 hours or more before any other diagnostic laboratory
tests a.re obtained.

A favorable response to a uricosuric drug by

a patient suspected of having gout on the basis of other factors

-13-

m~~es

the diagnosis of gout vertually certain.
DIF'FT~EL~NTIAL

DIAGNOSIS

Since there are a nUJnber of conditions lvhich simulate gout
and gouty

2~thritis

it is necessary to be able to recognize these

conditions and rule them out when attempting to diagnose a case of
gout.

Acute rheumatic fever and acute gouty arthritis are very

difficult to differentiate.

The age of the patient may be of some

help in differentiating but certainly cannot be used as the sale
factor since older -persons Y'Jay have rheumatic fever just as young
individuals may have gouty arthritis.

Articular distress is usually

more acute in gout than in rheumatic fever.
also be of significance.

The sex incidence may

A young female patient -v.rith acute arthritis

is much more likely to have rhe'U1n2.tic fever than gout.

Likelflse,

an elderly male "ldth articular cO:1'plaints is more likely to have
gout.

Electrocardiographic changes and cardiac pY!llptoms favor a

diagnosis of rheumatism.

Other differentiating factors include

response to colchicine and radiographic evidence.

X-rays of

rheumatic joints ShOl>l soft tissue slrelling only without evidence of
bony changes.
Another Significant disease which must be ruled out before
making a diagnOSis of gouty arthri.tis is rheumatoid arthritis.
differential in this case should not be so difficult to make.

'TIle
In

rheumatoid arthritis the joints tend to be involved symmetrically,
and the onset is not so sudden nor the articular pain so unbearable.

-lh-

The duration of attacks is longer for rheumatoid arthritis than
for gout.

This is not to

s~

that theEe two conditions cannot occur

concomitantly in the sa.'Tle patient, in 1ihich case the differentiation
would be fore difficult but less necessary.
diagnosis may

~w~s

Of course, the final

be readily made histologically from biopsy of

a tophus or a synovial membrane.
In older patients osteoarthritis, or degenerative joint
disease, must be considered in the differential diagnosis with
gouty arthritis.l~

The Heberden's nodes, which occur on the terminal

interphalangeal joints, may somewhat resemble the tophi found in
gout.

It seems, however, that ioJOmen are more prone to the develop-

ment of acute Heberden's nodes; therefore, since women seldom have
gout, the differentiation here should usually be re 1 at ive 1:'0" easy.
IUS 0

,

acute articular s:ylllptoms are rare :i_n osteoarthritis and are

the rule in gouty arthritis.
Septic joint involvement has been mentioned previously in the
section on diagnosis.

However, it should be mentioned again since

the symptoms of sepsis in a joint "rill probably most closely
resemble those of gouty arthritis.

A septic joint, like a gouty

joint, may be red, warm to the touch, swollen, and extremely tender,
although probably not quite so exquisitely tender as a gouty joint.
It should be again emphasized that it behooves the attending
nhysician to attemnt to differentiate these two conditions because
".

l:.!

...

of the fact that antibiotics may aggravate gout.

-15-

PIlEVENTIOlJ Al\1J) TREAT1·1ENT

S'ince gout is generally held by authorities to be a disease
of hereditary origin there is little in the way of prevention that
can be done unless one is able to pick his ancestors.

This, we must

presume, lies beyond the scope of medical science, at least for the
present.

It is kno'W""!l that persons, especially males, whose parents

or grandparents have gout are much more likely than others to have
elevated serum uric acid levels, if not clinical gout.
ities

l~~ould

Most author-

probably agree that relatives of known gout patients who

have hyperuricemia

~~thout

potential gout victims.

symptoms should be informed that they are

Such individuals should avoid obesity,

excessive trauma to joints, and high purine foods.

Hyperuricemic

indiiTiduals should be identified by the physician as potential gouty
patients so that 1men and if the initial acute attack occurs it may
be correctly diagnosed aTJ.d the proper treatment recommended.

Of

course therapy in gouty subjects should be directed toward the
nrevention of the chronic tophacious 11anifestations which may be
disabling in severe cases.

This can be done with proper therapy

in a cooperative patient.
It has been previously stated that gout is the only arthritic
condition that C8n be effectively treated at present.

Therefore, it

is proper that considerable attention be naid to the treatment of
gout.

It should be understood at the beginning that gout cannot

be cured.

It is, h01l1ever, a chronic disease that can be effectively

-16-

treated to reduce the number of acute attacks and to prevent the
chronic manifestations.

It is this IItreatmentll with which we will

concern ourselves here.
Colchicine is one of the oldest drugs in the pharmacopeia and
has been known for many years to be specific in the treatment of
gout.23

The autumn crocus or Colchicum auturrlllale, the source of

colchicine, hAS been in use since 600 A.D. according to GrahamJ'
Ho,rever, the mechanism of the action of colchicine remains a
mystery even today.

This drug is the active prinCiple of the

tincture of colchicum and is present in many species of plants of
that genus.

It is not an analgesic drug and 1s useless as treatment

in other t:vpes of arthritis.

Another irnportant fact is that

colchicine is not a uricosuric agent, nor 1s it a diuretic.
Colchicine seems to be specifically effective for regular use as
a prophylactic agent in the gout patient, and it is especially
helpful in relieving the symptoms of the acute attack of articular
distress.

In treating the acute 8.ttack it is recommended that

colchicine be given in doses of 1 mg. every tV-TO hours for five
doses the first day of the attack and in smaller doses as the
attack diminishes.

If very rapid action is necessary or desired

colchicine may be administered intravenously in doses of 2 to 3
mg. given slowly.5,20,23
hours.

This produces dramatic relief in about three

Because of its irritating

effec~

care should be taken to

place the colchicine directly into the vein and not into tissue.

-17-

As

mentioned above conchic:Lne is recommended for use during

the intercritical period between acute attacks.
dosages of

In this capacity

0.5 mg. are given three or four days each l'feek in the

milder cases, and one tablet each day in more severe cases. 28

The

use of colchicine has been found to be beneficial in pro1:)hylaxis
against the acute att2.ck especially in combination
wilich will be discussed 18.ter.
toler2.ted

1~nen

\u th

Benemid

Colchicine is apparently well

taken over long neriods of time and sensitivity does

not seem to develop.2'?

Unfortunately the toxic and full therapeutic

doses are very close together, and this fact is frequently used to
determine the maximum tolerable dose for a given patient With severe
gout.;i;O

The toxic or side effects of excess colchicine intake are

usually confined to the gastrointestinal tract.
include nausea, vomiting, and abdominal pain.

These symptoms
Gastrointestinal

upset is apparently not a factor '({hen the drug is administered intravenously, so this route is recommended for attacks of gout which have
been precipitated by surgical trauma.
Phenylbutazone (Butazolidin) is another drug which is effective
in the treatment of gout lmen administered orally. 23

This drug has

the advantage of being an excellent analgesic agent as well as
having anti-inflammatory properties.

Phenylbutazone should be

started soon aSter the onset of symptoms.

A large initial dose

of 400 to 600 mg. is follolred two hours later by 260 mg. and four
hours after that by another 200 mg., thus making a total of 800 to
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1000 mg. for the first day.

The follovring two or three days

hoo

mg. daily should be given in divided doses until symptoms have
disappeared.

The relief of symptoms "nth this drug is rapid, but

numerous undesirable side effects may result.

Among these are salt

and water retention which may lead t.o congestive heart. failure and
acute pulmonary edema.

Nausea, vomiting, nervousness, insomnia,

skin rashes, blurring of vision and bone marrOvJ depression have also
been attributed t.o phenylbut.azone. 23

Thus phenylbutazone is not

recommended for long term or prophylactic administration.
Probenecid (Benemid) (p-(di-n-propylsu1famyl)-benzoic acid)
was s3mthesi#ed following the observation by Wolfson and associates
in 1948 that carinamide inhibited uric acid reabsorption. 23

Benemid

has no analgesic or anti-inflammatory properties and is of no value
in controlling the acute attack of gout.
gout.

As

l~either

is it a cure for

a matter of fact, Benemid he.s been found to actually

increase the number of acute attacks during the first few months of
its administration.

HOwever, this drug has been found to be of

significant value in the prophylaxis of acute attacks when it :is
used conscientiously over periods of several

~nnths

to several years.

Benemid seems to be more effective when used in combination with
colchicine.
Benemid, unlike colchicine, is a urate diuretic drug or, as
it is more commonly called, a uricosuric agent.

It acts by reducing

the tubular absorption of glomerular filtered urate and is
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associated with an increased excretion of uric acid in the urine,
a decreased concentration of uric acid in the serum, and a decrease
in the metabolic poo1. 4,23
Probenecid was originally developed for the specific purpose
of inhibiting renal tubular secretion of penicillin.

?nis property

was extremely useful in the early days of penicillin when this
substance wac scarce and expensive. la

Since penicillin is excreted

as penicillin and is not broken dOrm or detoxified in the body it
is obvious that an agent which would provent tubular secretion of
this drug 1-lou1d be very useful :1.n maintaining adequate blood levels
of the antibiotic.

It was later found that probenecid

1.va8

useful

as a uricosuric agent and it is in that capacity that th:1_s drug
is used to a great extent.

Sirota &'1d associates reported in 1952

that Benemid. has no significant effect on glomerular filtration,
and that

tI

data obtained support the complete filtration-partial

tubular reabsorption concept of urate excretion in the normal and
gouty subject and indicate that Benemicl uricosuria is the result
of a highly selective i!ll1ibition of tubular reabsorption of filtered
urate rr • 1§
App8xently there is some antagonism between Benemid and
sa1icy1ates, which are uricosuric in their own right.
reason it is

recon~ended

simu1taneous1y.4

For this

that these two agents not be used

There do not B'3errl to be any significant toxic

side effects of Benemid.

.Uso, mild renal dysfunction is not a
-20-

contraindication to the use of Benelnid. 23
Benemid therapy for prolonged

~eriods

Patients who have ~en on

may even show Lmproved renal

function as evidenced by blood urea nitrogen determinations.

This

is thought to be due to the fact that Benemid may cause gradual
depletion of urate deposits

t~ich, ~nen

present in the kidney, may

interfere 'i>"nth renal function to some degree.
In addition to the drugs discussed above, adrenal steroids have
been used in treatment of gout.

These agents, while they may be

helpful in treating acute symptoms, Ere not recommended for prolonged administration.

Likewise, the saliqylates, acetylsalicylic

acid and sodium salicylate, have long been known to be useful in
treatment of gout.
properties.

Their chief merit probably lies in their analgesic

As previously mentioned, however, there is some sort of

antagonism between salicylates and probenecid which makes it
inadvisable to use these two agents together.
In general there are about four stages ot gouty disease each

of v1hich is somevihat unique in its therapy.
follows:

These stages are as

stage I, the stage of asymptomatic hyperuricemia; stage

II, the acute attack; stage III, the intercritical periods; and
stage IV, the stage of chronic gouty arthritis.
HYPeruricemia, as has been previously mentioned, is frequently
found in relatives of gout patients.

In general, this condition.

should serve only to alert the physician to the possibility of gout
in such persons

80

that the proper diagnosis can be made in the case
-21-

of acute onset of articular distress.

There is no actual therapy

duri..'1g this stC',ge because only a percentage of such persons will
actually demonstrate clinical gout during their lives.

However, the

physician can recommend the avoidance of obesity, joint trauma, and
high purine diets for these people. 20

Like~dse, periodic checks

should probably be made of the uric acid level to keep track of
any progression of the disease.
The a.ctual diagnosis of gout is not usually made lh'1til the
appearance of the first acute episode of joint distress.
nosis should then be positively made.

The diag-

As mentioned above, a history

of hyperuricemia makes the diagnosis much easier because the attending uhysician

~dll

be immediately alerted to the diagnosis.

At any

rate this is stage II, the acute attack, and it is here that the
treatment of gout first begins.

Colchicine should be administered

at the first sign of articular distress in order to ward off the
severe uain so characteristic of acute gout.
available in

0.5

mg. (1/120 grain), should be

Colchicine tablets,
t~~en

every hour or

two until pain is relieved or the toxic symptoms occur.

Control of

the usual attack will require from eight to sixteen tablets.
Known gout sufferer;:;) should never be far from a supply of colchicine
tablets because the earlier the medicat/Lon is started during an acute
attack the quicker relief will be attained. 23

It has been previ-

ously stated that probenecid may precipitate acute attacks during the
first few months of its administration.
-22-

It should be pointed out

here that if an acute episode of gouty arthritis occurs during
probenecid therapy, colchicine or phenylbutazone is indicated in
therapeutic

a~ounts,

but the probenecid should be continued with-

out change in dosage.
Stage III, the intercritical periods, .fhich will comprise
the greatest length of time in the early years of a gout Datient's
history, should probably receive special ettention.

'The aim of

therapy during the intercritical periods is to reduce or prevent
reCl~renccs

of acute erticular distress.

combination of colchicine with Benemid.

The best therapy is the
Colchicine will relieve

the acute attack and may be giVen over long periods of time 1tlithout
the appearance of toxicity or increased tolerance.

It has been found

that patients who helVe been on colchicine for many years will still
receive a full therapeutic response to this drug during an acute
episode.

Benemid, on the other hand, is effective in lowering the

uric acid level of the serum and thus viiI I frequently prevent the
occurrence of acute episodes by bringing the uric acid down to
normal levels.

As much as 2 Gm. of Benemid per day ;,)ay be given

to severely afflicted persons.

It is recommended that a high intake

of fluids be maintained during a high dosage regimen in order to
inhibit preciDitation of urates in the renal tubules.

Since Bene-

mid Causes an increased excretion of urates, it makes sense to offer
the kidney a large volume of "rater lnth which to carry away this
increased volurne of urates.

J.n alkaline urine is also considered
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to be helpful in the prevent~,-on of urate deposition in the kidney. 4
This can be accomplished by

adrr~p2stration

of sodium bicarbonate.

Alkalinization should be continued as long as uricosuric therapy
is causing an excess production of uric acid in the urine.

The

excess tends to decline as the wiscible pool approaches normal.
Probenecid is excreted only by glomerular filtration and
disappears slowly from. the circulation even in the presence of
impaired renal fUnction.

A daily dose of probenecid of 2 Gm. is

sufficient to sustain, in normal persons, a plasma concentration
between

h and

10 rug./IOO ml.

It is possible to chemically evaluate

the plasma concentration of Benemid, but the PSP test is

a sensitive

indicator of inhibition of renal tubular function by Benemid.

If

the PSP is depressed during Benemid therapy, this indicates that
the uricosuric and penicillin enhancing effects will also be

present.~h
Stage IV, the stage of chronic gouty arthritis, represents the
end result of long term gouty

diseas~.

1bis stage is characterized

by tbe presence of tophi and low grade aches of the involved joints.
It is hoped that, it proper management of the disease is exercised
by the physician, there will not be a progression to this advanced
stage.

F~w~ver,

should this stage be reached in the natural

history of gout it is well to be prepared to treat it.
'The drugs used for treatment of stage IV are the same as those
reconnnended for stage III, e.i. colchicine and Benemid.
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Since acute

attacks of joint distress may stiH occur during the chronic
tophaceous stage it is necessary to maintain the patient on
colchicine.

It should be noted here that the response to treat-

ment of the acute episode may not be as rapid or complete as
during earlier stages, and several courses of colchicine may be
necessar:'l to bring such an attack under control. 19 It is in the treatment of this chronic stage that Benemid becomes almost indispensable.
DJ causing an increased excretion of urates this drug Droduces a

reversal of the flow of urates from subcutaneous and articular areas
and thus effects a decrease

in the size of

vents the formation of any new tonhi.
needed to reduce the

serQ~

existL~g

tophi and pre-

The dosage is the amount

uric acid level to

norw~l.

If renal

calculi are present the dosage should be no greater than

1.0 Gm. per day.

0.5

to

Of course a large fluid intake as well as alk-

alinizatior of the urine should be employed as discussed above.
By following the therapy outlined above for the various stages

of gout it is possible to keep most gout patients symptom-free while

not restricting the patient severly

in diet or activity.

It is

generally agreed, that temperance should be exercised by the patient
as far as alcoholic

and high purine food intru{e is concerned but

total abstinence is not necessary_
PROGNOSIS
A paper dealing vdth a disease such as gout would not be
complete without a discussion of the prognosis.
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As

was stated above,

none of the arthritic conditions is curable.

Gout, hovrever, is the

one such condition Iv-hich can be effectively treated and controlled.
We should repeat here that in order to effectively treat a gouty
patient it is extremely important that the DPtient cooperate.
Patients

~mo

fail to follow the physician's orders or fail to take

their medications regularly will, in all probability, continue to
suffer from the

mala~y.

However, the prognosis in cooperative

patients is good in general.

This is especially true if the disease

is diagnosed and treatment instituted early.
One of the most orrdnous prognostic signs is the formation of
renal calculi and severe renal disease.

It has been previously

pointed out that renal calculi may be treated effectively by Benemid
therapy, and that renal function may be improved by the chemical
removal of such calculi.

Hawver, if prirnary renal disease or renal

vascular disease is present the prognosis is l1mch poorer because
the effectiveness of the drugs depends upon the kidneys.
ho~rever,

In general,

gout is the most gratifying of the arthritides to treat,

and the prognosis is to be considered quite good from the stan.dpoint of control of

~~otoms

and chronic manifestations of the

disease.
SUl'1fIARY

On the preceding pages 1<Je have endeavored to present a concise

but complete picture of gout.

Gout is a disease "Thich has plagued

man for centuries, being mentioned in eprly writings including the
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Bible.
is

nO\,-I

Unlike other arthritic conditions, gout is treatable.

It

genarally accepted that anyone \'-Jho suffers from gout does

so needlessly.

Herein lies the responsibility of the physician,

e.i., to make an honest effort to rule out a diagnosis of gout before
allowing a patient to suffer with this condition thinking it is
a nontreatable form of arthritis.
Gout is IGlown to be an

heredit~~

disease, and its incidence

is obviously sex-linked since it attacks males in a ratio of

95.5/4.5

over females.

It is also included among the "inborn

errors of metabolism" and is linked to purine metabolism and
uric acid concentrations in the serum.

Recent studies using iso-

topically labeled uric acid have confirmed and clarified much of
the etiology of gout.
The clinical aspects of gout .uth its severe joint distress
are included in detail in the preceding pages.

Gout should be

considered in the differential diagnosiS of any acute inflamIl1atory
joint.
The currently accepted cOIrrbined therapy using both colchicine
and probenecid is described in some detail, as well as the pharmacologic background and adion of these drugs.

Although other

drugs may be useful in treatment of gout it is felt

th.2~t

the

above drugs provide the best advantage for continued long-term
therapy.
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ADDENDID1

,since the completion of this manuscript, certain articles
have come to my attention which appear to shed new light upon
the possible mechanism of action of colchicine in the treatment
of gout.
Seegmiller and Howell, in an article published in June of

1962, proposed that colchicine diminished the metabolic activity
of the leukocyte Which causes decreased phagocytosis and lactic
acid production.

They hypothesized that this would

interl~pt

the

cycle of rapid crystal deposit, inflammatorJ response and phagocytosis of those crystals which is characteristic of acute gout.

These

two investigators were able to demonstrate an in vivo as 1"ell as
an in vitro effect of colchicine at therapeutic levels.

They pre-

treated gouty volunteers with therapeutic doses of colchicine and
found that the inflammatory response to the injection of s9dium
urate crystals was substantially reduced.
decreased

pha~ocytosis

They demonstrated the

effect of colchicine in an in vitro system

using urate crystals and human leukocytes.

Since phagocytosis

increases lactic acid production by granulocytes, they reasoned
that a decrease in phagocytosis might sufficiently reduce the local
lactic acid production to interrupt the cycle mentioned above. 31 ,32
Snodell published a student thesis in August of 1962

~mich

suggests that colchicine may have some effect upon the metabolism
of purines.

He found that the rat intestine is eble to convert

various purine compounds to uric acid under in vitro conditions.
He observed that colchicine stimulated the oxidation of hypoxanthine
to uric acid by the rat intestine.

Colchicine appeared to inhibit

the conversion of inosine, the riboside of hypoxanthine, to uric
acid.
that

He offered no explanation of these findings but suggested
lI

colchicine may exhibit its therapeutic properties in gout by

altering some phase (s) of purine metabolism,,}3
Thus

w'"e

see that there is evidence to support at least two

possible mechanisms of action of colchicine in gout.

hhile either

of these possibilities seems plausible as an explanation of the
action of colchicine, the fact that there are two such possibilities
only serves to emphasize the fact that in all probability the final
word on the mechanism of action of colchicine in gout has not been
written.
ation.

This topic certainly remains open for further investigWhile many of the actions of colchicine are known, its

action in gout remains today mostly within the realm of hypothesis.

CotJCLUSIONS
A.cute joint distress m8y be the primary manifesta,tion of a
number of diseases which we usually place in the general category
of arthri tic conditions.

Undoubtedly some of the so-called anth-

ritis sufferers are actually enduring needless pain and discomfort of
treatable gouty arthritis rather than one of the untreatable forms.
This is needless suffering because i'rl.th proper diagnosis and careful managexnent almost untold relief could be afforded these :oeople.
It is the responsibility of the physician to recognize these persons
and possibly prevent their suffering from gouty arthritis.

I believe

that the greatest fault of physicians is their failure to think of
gout e,s a possibility in cases of 2.cute joint distress.
diagnosis of gout; once it is thought of; is not difficult.
patient vii th articular distress l.;ho

:.8

Yet the
Any male

in the middle age group

should be considered a prL'Tle candidate for gout, especially in the
presence of a family history of gout.
The serum uric acid level may

virtuC'~ly

cinch the diagnOSis

of gout; hOi'Jever, this test is not particularly easy to perform
and a reliable laboratory should be consulted for this determination.
It should be remembered that uric acid level may not accurately
reflect the severity of the clinical manifestations.
may show

syrr~toms

Some persons

of gout at relatively low uric acid concentrations

while others may be symptom free at much higher uric acid levels.
In general, however, no attempt to diagnose the condition should be
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made until e.fter the occurence of the first acute attack of joint
distress.

Since gout is hereditary and thus a familial disease,

all close male relatives of gout sufferers should have uric acid
determinations to discover nonsyrnptomatic hJrperuricemias.

Any

such relative who is found to have a hyperuricemia in the absence of
symptoms should be ir...formed of this fact and its implications.

He

should also be noted by the physician as a potential gout pa.tient
so that when articular s;:rmptoms do develop the correct diagnosis
may be made and treatn'lent instituted early.
H.any' of'the ideas'previously held by'physicians concerning

gout have been dispelled by closer evaluation arrl recent studies.
For

ex~~le,

it has long been thought that gout was a disease

acquired mainly by Europeans from overindulgence in food or drink.
~~

now know that gout is an hereditarJ condition, and is very

little, if any, affected by diet.

Since uric acid is a product of

purine metabolism, it is advisable for severe gout sufferers to
abstain only from those foods 'tihich are high in purines.
The essential thing to remember is that the diagnosis of this
disease is the responsibility of every physician who practices
general medicine and treats arthritic conditions.

Since gout is

the only one of these painful conditions which can be effectively
treated and relieved the physician should

m2~e

special effort to

determine ",nether any of hiE arthritic cases could possibly have
been originally misdiagnosed, and whether one of his ltarthritisll
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patients may, in fact, be suffering from the treatable condition
of gout.

I believe that physicians should periodically review their

cases of arthritis patients to seek out possible gout sufferers, and
to attempt relief of their suffering.

Serum uric acid determinations

should be a principal part of the work-up of every case involving
articular distress.

Likewise, as has been previously mentioned,

relatives of gout patients shou1d be cardfully screened as possible
future gout patients.

This is especially true of males.

'Ihe most

important aspect in the diagnosis of gout remains, however, merely
to

thi~~

of it as a possibility.
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